At Nostos Genomics, we partner with genetic testing labs to give more people with genetic diseases a fast and clear diagnosis. Over 300 million people live with a rare genetic disease and for most, the journey from the first symptoms to a diagnosis takes more than 5 years. Even after that, diagnoses are often incorrect, and many people end up not being diagnosed at all. Now, new technology is allowing millions to benefit from genetic testing for diagnosis, while at the same time targeted therapies for previously untreatable disorders are being developed. But the last step in genetic testing – interpreting mutations – remains laborious and costly. It can take a genetic testing lab weeks to interpret data from a single patient. Because of limited understanding of the consequences of mutations, the test results are often inconclusive and leave 70% of people undergoing a genetic test without diagnosis.
Our platform leverages a unique combination of machine learning and synthetic biology to characterize mutations at scale and automate the interpretation. By offering it to labs, we enable them to diagnose more people in a fraction of the time.
B2B
26 to 50
Funded
N/A
Scaling Up
2018
Managed Health Care
Healthcare
Biotechnology
N/A
Revenue Growth
Analytics
IT and Security
Service
Yes
Active
Machine Learning
Machine Perception
N/A
Software
N/A
N/A
4
1
$5.7M
Company was founded 2018 and it took almost 4 years (Feb 2022) to raise first external round
Investors
Interested in researching Nostos Genomics?
We have plenty of data and we can help. Our deal sourcing platform can help you perform more research about Nostos Genomics
Potential Customers
Interested in what they do or partnership?
Learn more about how they work